Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression-Reference-Cited by-同舟云学术

Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression

Published:2015-05-26 Issue:2 Volume:102 Page:188-194
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Miyazaki Kana,Yamaguchi Motoko,Imai Hiroshi,Kobayashi Kyoko,Tamaru Satoshi,Kobayashi Tohru,Shiku Hiroshi,Katayama Naoyuki

Funder

the Ministry of Education, Culture, Sports, Science, and Technology

the National Cancer Center Research and Development Fund and the Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare in Japan

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-015-1812-2.pdf

Reference33 articles.

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008.

2. Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, et al. De novo CD5 + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815–21.

3. Miyazaki K, Yamaguchi M, Suzuki R, Kobayashi Y, Maeshima AM, Niitsu N, et al. CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Ann Oncol. 2011;22:1601–7.

4. de Jong D, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Lee A, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications–a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol. 2007;25:805–12.

5. Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, et al. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma–a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL). Ann Oncol. 2007;18:149–57.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma;Virchows Archiv;2024-05-11

2. Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice;International Journal of Hematology;2023-05-02

3. Clinicopathologic Features and Genomic Signature of De Novo CD5+ Diffuse Large B-Cell Lymphoma;American Journal of Surgical Pathology;2022-08-26

4. Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx;Frontiers in Oncology;2022-08-23

5. De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients;Annals of Diagnostic Pathology;2022-06